IL15 and neoplasm: Engineering CARs to provide immunostimulatory signals have relied on IL‐12 secretion, IL‐15 expression, and redirecting immunosuppressive cytokines (eg. IL‐4) resulting in increased survival CARS resistant to immunosuppressive factors in the hostile tumor microenvironment such as TGF f‐mediated inhibitory signals have been developedTM.